These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1768284)

  • 1. Uptake, cytotoxicity and metabolism of m-azidopyrimethamine and related lipophilic antifolates in SV-K14 human keratinocytes in vivo.
    Baker ND; Griffin RJ; Irwin WJ; Reichert U; Schmidt R
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S39-46. PubMed ID: 1768284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine.
    Assaraf YG; Slotky JI
    J Biol Chem; 1993 Feb; 268(6):4556-66. PubMed ID: 8440739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
    Jansen G; Barr H; Kathmann I; Bunni MA; Priest DG; Noordhuis P; Peters GJ; Assaraf YG
    Mol Pharmacol; 1999 Apr; 55(4):761-9. PubMed ID: 10101035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydrofolate reductase and cell growth by antifolates in a methotrexate-resistant cell line.
    Hamrell MR
    Oncology; 1984; 41(5):343-8. PubMed ID: 6540852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
    Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
    Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics and consequences of folate depletion in hepatoma cells in vitro by inhibition of dihydrofolate reductase.
    Galivan J; Nimec Z; Rotundo R
    Adv Enzyme Regul; 1989; 29():209-17. PubMed ID: 2633609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
    Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
    Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor.
    Stuart NS; Crawford SM; Blackledge GR; Newlands ES; Slack J; Hoffman R; Stevens MF
    Cancer Chemother Pharmacol; 1989; 23(5):308-10. PubMed ID: 2706736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates.
    Bram E; Ifergan I; Shafran A; Berman B; Jansen G; Assaraf YG
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):826-34. PubMed ID: 16612649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
    McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
    Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells.
    Fyfe MJ; Sedwick WD; Brown OE; Laszlo J
    J Natl Cancer Inst; 1981 Mar; 66(3):445-51. PubMed ID: 6937701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
    Taylor IW; Slowiaczek P; Friedlander ML; Tattersall MH
    Cancer Res; 1985 Mar; 45(3):978-82. PubMed ID: 3971388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.
    Cavallito JC; Nichol CA; Brenckman WD; Deangelis RL; Stickney DR; Simmons WS; Sigel CW
    Drug Metab Dispos; 1978; 6(3):329-37. PubMed ID: 26555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracellular mechanism of action of metoprine (DDMP).
    Browman GP; Calvert AH; Taylor GA; Hart LI; Harrap KR
    Eur J Cancer (1965); 1980 Dec; 16(12):1547-54. PubMed ID: 6971755
    [No Abstract]   [Full Text] [Related]  

  • 18. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
    Assaraf YG; Ifergan I; Kadry WN; Pinter RY
    J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in enzyme activity and expression of DHFR of Toxoplasma gondii by antifolates.
    Baek EJ; Nam HW
    Korean J Parasitol; 1998 Sep; 36(3):191-8. PubMed ID: 9755590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin sodium: pronounced effects on methotrexate transport and anti-folate activity in cultured tumor cells.
    Rideout DC; Bustamante A; Patel R; Henderson GB
    Int J Cancer; 1995 Jun; 61(6):840-7. PubMed ID: 7790120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.